Start date: 01.11.2019
Kateryna Solodka, originally from Ukraine, graduated in 2018 in Pharmacy from the University of Valencia, where she continued her academic career by completing a Master’s Degree in Research and Rational Use of Medicines in 2019. During her Bachelor’s project, she worked at the Pharmacology Department of the University of Valencia studying the role of G-protein-coupled receptor kinase 2 and its implication in cardiometabolic disorders, obtaining a special distinction for this work. She completed her Master’s Thesis at the Faculty of Medicine of the University of Valencia and the INCLIVA Biomedical Research Institute, studying the role of constitutive nuclear androstane receptors in endothelial dysfunction. In this way, she gained experience with basic techniques of immunohistochemistry, immunofluorescence, ELISA, western blot and leukocyte-endothelial cell interactions ex vivo assays.
In November 2019, Kateryna started her PhD studies at the Department of Life Sciences of the University of Modena and Reggio Emilia (Italy), under the supervision of Professor Marcello Pinti. Her research activity involves the investigation of biosensors based on electrolyte-gated organic field-effect transistors (EGOFET) for the detection of multiple sclerosis biomarkers in plasma.